13-Feb-2026
No headlines found.
TrueBlue to Announce Fourth Quarter and Full-Year 2025 Results
Business Wire (Wed, 4-Feb 4:05 PM ET)
TrueBlue Brands Earn ClearlyRated Best of Staffing 2026 Awards for Sustained Service Excellence
Business Wire (Wed, 4-Feb 8:00 AM ET)
TrueBlue President and CEO Taryn Owen Named a Most Influential Leader in Global Staffing
Business Wire (Tue, 20-Jan 8:00 AM ET)
Business Wire (Thu, 8-Jan 5:31 PM ET)
EHS Announces Three Highly Qualified Director Nominees for Election to TrueBlue Board
PRNewswire (Thu, 8-Jan 9:45 AM ET)
Business Wire (Wed, 10-Dec 8:00 AM ET)
TrueBlue Appoints Two New Independent Directors
Business Wire (Tue, 2-Dec 11:59 AM ET)
EHS Announces Intent to Nominate Directors at Upcoming TrueBlue Annual Meeting
PRNewswire (Tue, 2-Dec 9:45 AM ET)
Business Wire (Mon, 17-Nov 8:00 AM ET)
TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.
Trueblue trades on the NYSE stock market under the symbol TBI.
As of February 13, 2026, TBI stock price declined to $4.53 with 117,978 million shares trading.
TBI has a beta of 1.00, meaning it tends to be more sensitive to market movements. TBI has a correlation of 0.08 to the broad based SPY ETF.
TBI has a market cap of $134.58 million. This is considered a Micro Cap stock.
Last quarter Trueblue reported $431 million in Revenue and $.03 earnings per share. This beat revenue expectation by $23 million and exceeded earnings estimates by $.12.
In the last 3 years, TBI traded as high as $19.51 and as low as $3.45.
The top ETF exchange traded funds that TBI belongs to (by Net Assets): FNDA, VTI, IWM, AVUV, VXF.
TBI has underperformed the market in the last year with a price return of -38.8% while the SPY ETF gained +13.0%. TBI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -8.1% and -15.5%, respectively, while the SPY returned +1.7% and -1.5%, respectively.
TBI support price is $4.43 and resistance is $4.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TBI shares will trade within this expected range on the day.